Beyond Air™ Reports Financial Results for Fiscal First Quarter 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Beyond Air, Inc. (XAIR) Misses Q1 EPS by 39c
August 14, 2019 4:14 PM EDTBeyond Air, Inc. (NASDAQ: XAIR) reported Q1 EPS of ($0.67), $0.39 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $627.47 thousand versus the consensus estimate of $1.06 million.
Key Highlights
Remains on track to file a Premarket Approval (PMA) submission with the FDA for the treatment of persistent pulmonary hypertension of the newborn (PPHN) with our LungFit* PH system in the third quarter of calendar 2019. Anticipates obtaining CE Mark for LungFit* PH for the treatment of PPHN and for the treatment of pulmonary hypertension associated... More